A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
Author:
Affiliation:
1. Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York.
2. Beijing Institute of Microbiology and Epidemiology, Beijing, China.
3. Department of Microbiology, the University of Hong Kong, Hong Kong.
Publisher
Mary Ann Liebert Inc
Subject
Virology,Molecular Medicine,Immunology
Link
https://www.liebertpub.com/doi/pdf/10.1089/vim.2009.0090
Reference60 articles.
1. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
2. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
3. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
4. Mucosal immunisation of African green monkeys ( Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
5. Immunogenicity of the outer domain of a HIV-1 clade C gp120
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insights into the Structural Complexities of SARS-CoV-2 for Therapeutic and Vaccine Development;Combinatorial Chemistry & High Throughput Screening;2023-09
2. Application of Traditional Vaccine Development Strategies to SARS-CoV-2;mSystems;2023-04-27
3. Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review);Experimental and Therapeutic Medicine;2022-11-30
4. Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate;Vaccines;2022-06-03
5. SARS-CoV-2 vaccines: current trends and prospects of developing plant-derived vaccines;Biomedical Innovations to Combat COVID-19;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3